Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Short Interventions to Prevent Trapezius Muscle Fatigue in Computer Work

1 marzo 2019 aggiornato da: Swiss Federal Institute of Technology

Trapezius Muscle Fatigue of Long Duration: a Likely Neuromuscular Control Issue

This study is expected to demonstrate that during experimental days of seated computer work sustained and focalized low-level muscle activity contributes to the development of long-lasting fatigue effects (and thus possible disorder). On days with and without frequent interruptions, signs of fatigue and the activity pattern of the trapeze muscle are registered and compared using electromyographic registrations of the trapezius muscle.

Panoramica dello studio

Descrizione dettagliata

30 healthy adults without chronic neck pain participated in a laboratory study designed to simulate two full workdays of computer work. Within each session, participants performed five 50-min working activities separated by 10-min breaks: i) Use a computer keyboard to type a text presented on the left side of the screen; ii) do the typing task with the desk height set10 cm above elbow height; iii) play the computer game Spider Solitaire implemented in Windows 10; iv) Stroop test (This test consists of reading the name of a color whose text is in a color different from the name. The color name was then selected from a multiple-choice panel displaying color names; v) the same online puzzle game was presented to all participants. Assembling the puzzle was performed by drag and drop actions. The work periods were not disrupted (on the "control day") whereas two short interruptions of 5-min were introduced at 1/3 and 2/3 of each working period on the "intervention day". During these interruptions, participants were asked to perform "muscle disrupting/relaxing" activities. For each experimental session a 30-min lunch break took place between the third and the fourth work periods. The specific sequence of work activity type and disrupting/relaxing activities was randomized across participants; however, for each participant the order of work activities remained the same for the two experimental sessions (control and intervention days). The order of control and intervention days was also randomized between participants.

A set of six measures were performed at specific time intervals during each experiment: before the first work activity, before and after lunch, immediately and 1 hour after the fifth (last) work activity: i) upper trapezius activation, assessed through the temporal EMG profile recorded by a single bipolar signal; and ii) through the spatio-temporal distribution of EMG activity detected by a 2D array of electrodes (64 channels); iii) muscle fatigue, quantified by changes in electrically induced muscle twitch force signals, iv) isometric performance, v) dynamic performance; iii) cognitive and physical load and stress level. In addition, personality traits (anxiety level), perceived workload and musculoskeletal symptoms were evaluated as covariates.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

30

Fase

  • Non applicabile

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 40 anni (Adulto)

Accetta volontari sani

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • healthy experienced computer workers

Exclusion Criteria:

  • chronic pain (more than 30 days within the last 12 months according to the Nordic Questionnaire (Kuorinka et al 1987);
  • pathologies of the neck,
  • prior and actual shoulder or neck pain caused by an accident,
  • skin disease in the neck or shoulder area,
  • BMI > 30,
  • sleep disorders (e.g. apnea, restless legs syndrome),
  • use of medications such as psychotropic drugs, muscle relaxants or analgesics within the last 3 days prior to the experiment,
  • pregnancy.
  • any shoulder/neck pain on the day before the experiment.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Prevenzione
  • Modello interventistico: Assegnazione sequenziale
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: short interruptions of work tasks
randomly start with or without short interruptions on the first experimental day and without or with them on the second experimental day

During each activity two interruptions/breaks were selected randomly from a set of ten predetermined actions:

Active break types:

  • Move shoulder and upper back
  • Swing arms near the body
  • Three slow but forceful elevations of the shoulders, a relaxation exercise based on the principles developed by Jacobson
  • Stand up and stretch
  • Slowly turn head in all possible directions.

Passive break types:

  • Tell a couple of jokes
  • Stand up and have a drink
  • Relaxing the trapezius
  • Questions on actual posture and feelings of comfort / discomfort.
  • A short rest on the couch

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
EMG profile recorded by a single bipolar electrode: Rest-time
Lasso di tempo: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Rest-time (percentage of time below 5% of the standard activity level). The percentage of registration time without any rest time is called sustained low level muscle activity.
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Area of muscle activity
Lasso di tempo: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined:

Area of muscle active region (n. of channels)

Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of muscle twitch
Lasso di tempo: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
3-D muscle twitch acceleration pattern measured at the acromion
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of dynamic force control accuracy
Lasso di tempo: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in an isometric dynamic tracking task
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
EMG profile recorded by a single bipolar electrode: Static activity
Lasso di tempo: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
p10 (level of the 10th percentile of the trapezius muscle activity) as an indicator of static activity primarily associated with continuous activity of the same pool of motor units.
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Magnitude of activity
Lasso di tempo: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined:

Magnitude of activity of muscle active regions (RMS sEMG).

Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Number of active epochs
Lasso di tempo: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Number of active epochs
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of static force control
Lasso di tempo: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in isometric isotonic low level contraction
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Muscle fatigue: Change of force control in ramp contraction
Lasso di tempo: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day
Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in isometric ramp contraction.
Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Localized musculoskeletal discomfort
Lasso di tempo: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
head-neck-shoulders-lower back-elbows-wrists-hip-upper legs-knees-ankles-feet-discomfort rated on 10 cm visual analog scales (adapted from Nordic questionnaire (Kuorinka et al 1987)
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
Visual and general fatigue
Lasso di tempo: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
10 cm visual analog scales
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
Effort
Lasso di tempo: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
6-20 Borg scale (6= no effort, 20=maximal possible effort)
At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day
EMG profile recorded by a single bipolar electrode: Dynamic activity
Lasso di tempo: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
p90 (level of the 90th percentile of the trapezius muscle activity) as an indicator of dynamic activity which may promote variability in the recruitment of motor units
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
Spatio-temporal distribution of EMG activity: Centroid of active regions
Lasso di tempo: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day
The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Centroid of active regions
Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Thomas Läubli, MD, Federal Institute of Technology Zurich

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

14 marzo 2016

Completamento primario (Effettivo)

5 settembre 2016

Completamento dello studio (Effettivo)

5 settembre 2016

Date di iscrizione allo studio

Primo inviato

14 dicembre 2018

Primo inviato che soddisfa i criteri di controllo qualità

1 marzo 2019

Primo Inserito (Effettivo)

5 marzo 2019

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

5 marzo 2019

Ultimo aggiornamento inviato che soddisfa i criteri QC

1 marzo 2019

Ultimo verificato

1 febbraio 2019

Maggiori informazioni

Termini relativi a questo studio

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • 32003B_160207

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi